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Background
cAMP and cGMP have been known for a long time to be
important second messengers in living cells, whereas
other cyclic nucleotides like cCMP or cUMP have only
been on the fringes of scientific interest. Recently, our
group has discovered that bacterial adenylyl cyclase toxins
produce a number of different cyclic nucleoside 5'-mono-
phosphates (cNMPs) apart from cAMP, and the interest in
specific and sensitive detection methods rises.
Common approaches for the identification and quantita-
tion of cNMPs are based on recognition of nucleotides by
antibodies in case of ELISA or RIA. Furthermore, nucleo-
side 5'-triphosphates (NTPs) labelled with [32P] at the -
position and read-out of the formed amount of radioac-
tively labelled cNMPs are routinely used [1]. In addition,
fluorescent assays have been recently developed either
depending on fluorescently labelled NTPs or on lumines-
cent probes like terbium(III) norfloxacin reporting the
turnover of ATP or GTP. However, all of these methods
show drawbacks like use of radioactivity, high costs, non-
availability of radioactive substrates or cross-reactivity of
antibodies with other nucleotides. Figure 1.
Our aim was to develop a universal method to detect all
cNMPs in one single measurement which is sensitive and
specific, and can be used for determination of cNMP con-
centrations in cell and tissue extracts, membrane prepara-
tions or with purified enzymes.
Methods and results
We have used a liquid chromatography (LC) coupled tan-
dem MS (MS/MS) system to separate cNMPs on a
reversed-phase column and to identify the specific mass
transitions by MS/MS (see Fig 1). Hence, we are able to
detect levels of cNMPs as low as approximately 3 nmol/L.
We used the bacterial adenylyl cyclase toxins edema factor
(EF) from Bacillus anthracis and CyaA from Bordetella per-
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Separation of cNMPs on a reversed-phase column and identi- fication by MS/MS at a concentration of 128 ng/mL Figure 1
Separation of cNMPs on a reversed-phase column 
and identification by MS/MS at a concentration of 128 
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tussis to record Michaelis-Menten-kinetics with ATP and
GTP as substrate. In contrast to generally held belief, both
enzymes showed turnover of GTP to cGMP, although with
low velocities.
Conclusion
We have developed a specific and sensitive assay for iden-
tification and quantitation of a number of cyclic nucle-
otides and have applied this method to determine the
formation of cNMPs at very low concentrations.
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